BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9209923)

  • 21. Systemic and renal growth hormone-IGF1 axis involvement in a mouse model of type 2 diabetes.
    Segev Y; Eshet R; Yakir O; Haim N; Phillip M; Landau D
    Diabetologia; 2007 Jun; 50(6):1327-34. PubMed ID: 17443310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging role of NO and IGF-1 in early renal hypertrophy in STZ-induced diabetic rats.
    Levin-Iaina N; Iaina A; Raz I
    Diabetes Metab Res Rev; 2011 Mar; 27(3):235-43. PubMed ID: 21309053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early and late changes in the diabetic kidney.
    Gundersen HJ; Mogensen CE; Seyer-Hansen K; Osterby R; Lundbaek K
    Adv Nephrol Necker Hosp; 1979; 8():43-62. PubMed ID: 115250
    [No Abstract]   [Full Text] [Related]  

  • 24. [Predicting diabetic nephropathy].
    Mogensen CE; Christensen CK
    Journ Annu Diabetol Hotel Dieu; 1984; ():333-49. PubMed ID: 6399537
    [No Abstract]   [Full Text] [Related]  

  • 25. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S; Nakamura T
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes.
    Tikellis C; Brown R; Head GA; Cooper ME; Thomas MC
    Am J Physiol Renal Physiol; 2014 Apr; 306(7):F773-80. PubMed ID: 24477684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The calcium channel blocker nitrendipine attenuates renal and glomerular hypertrophy in diabetic rats.
    Nielsen B; Gronbaek H; Osterby R; Orskov H; Flyvbjerg A
    Exp Nephrol; 1999; 7(3):242-50. PubMed ID: 10352365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes.
    Thomson SC; Deng A; Bao D; Satriano J; Blantz RC; Vallon V
    J Clin Invest; 2001 Jan; 107(2):217-24. PubMed ID: 11160138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Model's short life and murine resistance, another ''no'' revolution].
    Cornacchia F
    G Ital Nefrol; 2007; 24(4):282. PubMed ID: 17659494
    [No Abstract]   [Full Text] [Related]  

  • 30. Diabetic glomerulopathy: a dynamic process produced by the diabetic environment.
    Steffes MW; Brown DM; Mauer SM
    Adv Exp Med Biol; 1979; 124():157-66. PubMed ID: 116484
    [No Abstract]   [Full Text] [Related]  

  • 31. The kidney in diabetes: significance of the early abnormalities.
    Viberti GC; Wiseman MJ
    Clin Endocrinol Metab; 1986 Nov; 15(4):753-82. PubMed ID: 3536199
    [No Abstract]   [Full Text] [Related]  

  • 32. The point of no return in rat diabetic nephropathy: effects of pancreatic transplantation.
    Otsu I; Nozawa M; Tsuchida H; Hirose K
    Transplant Proc; 1992 Jun; 24(3):857-8. PubMed ID: 1604643
    [No Abstract]   [Full Text] [Related]  

  • 33. The TGF mechanism is not needed for development of glomerular hyperfiltration in diabetes.
    Skøtt O
    Acta Physiol (Oxf); 2007 Jul; 190(3):177. PubMed ID: 17581132
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetic nephropathy. Pathogenesis and prevention.
    Westberg NG
    Acta Endocrinol Suppl (Copenh); 1980; 238():85-101. PubMed ID: 6933819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
    Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic nephropathy.
    Hostetter TH
    N Engl J Med; 1985 Mar; 312(10):642-4. PubMed ID: 3974632
    [No Abstract]   [Full Text] [Related]  

  • 37. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
    Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
    Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth factors in the pathogenesis of renovascular complications of diabetes mellitus.
    Woolf AS; Bosch RJ; Fine LG
    J Hypertens Suppl; 1992 Apr; 10(1):S11-6. PubMed ID: 1535654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of diabetic nephropathy in the Milan normotensive strain, but not in the Milan hypertensive strain: possible permissive role of hemodynamics.
    Pugliese G; Pricci F; Barsotti P; Iacobini C; Ricci C; Oddi G; Romeo G; Leto G; Marano G; Sorcini M; Sabbatini M; Fuiano G; Di Mario U; Pugliese F
    Kidney Int; 2005 Apr; 67(4):1440-52. PubMed ID: 15780096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-Citrulline, but not L-arginine, prevents diabetes mellitus-induced glomerular hyperfiltration and proteinuria in rat.
    Persson P; Fasching A; Teerlink T; Hansell P; Palm F
    Hypertension; 2014 Aug; 64(2):323-9. PubMed ID: 24866144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.